CORRECTED-Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod
January 18, 2019 at 16:25 PM EST
The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.